カテゴリー： QYResearch, 世界

世界の胆管がん治療薬市場 2019年

【英語タイトル】Global Bile Duct Cancer Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X04528）・商品コード：DATA909X04528
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、胆管がん治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カボザンチニブS-リンゴ酸塩、エルパモチド、メシル酸エキサテカン、LY-2801653、NUC-1031、その他に、用途別には、病院、診療所、その他にセグメント区分し、胆管がん治療薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・胆管がん治療薬の世界市場概要
・胆管がん治療薬の製造コスト構成分析
・胆管がん治療薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・胆管がん治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・胆管がん治療薬のセグメント分析（種類別）
（カボザンチニブS-リンゴ酸塩、エルパモチド、メシル酸エキサテカン、LY-2801653、NUC-1031、その他）
・胆管がん治療薬のセグメント分析（用途別）
（病院、診療所、その他）
・胆管がん治療薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Ariad Pharmaceuticals, Inc.、ArQule, Inc.、Array BioPharma Inc.、Arrien Pharmaceuticals, LLC、Aslan Pharmaceuticals Pte. Ltd.、Bavarian Nordic A/S、Bayer AG、Blueprint Medicines Corporation、Boehringer Ingelheim GmbH、Boston Biomedical, Inc.、Bristol-Myers Squibb Company、Celgene Corporation、CellAct Pharma GmbH、Cellceutix Corporation、Cellular Biomedicine Group, Inc.、Concordia Healthcare Corp.、）
・胆管がん治療薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Bile Duct Cancer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Bile Duct Cancer Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Bile Duct Cancer Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Bile Duct Cancer Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Bile Duct Cancer Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Ariad Pharmaceuticals, Inc.
ArQule, Inc.
Array BioPharma Inc.
Arrien Pharmaceuticals, LLC
Aslan Pharmaceuticals Pte. Ltd.
Bavarian Nordic A/S
Bayer AG
Blueprint Medicines Corporation
Boehringer Ingelheim GmbH
Boston Biomedical, Inc.
Bristol-Myers Squibb Company
Celgene Corporation
CellAct Pharma GmbH
Cellceutix Corporation
Cellular Biomedicine Group, Inc.
Concordia Healthcare Corp.

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Cabozantinib S-malate
Elpamotide
Exatecan Mesylate
LY-2801653
NUC-1031
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Bile Duct Cancer Drug
1.1 Definition of Bile Duct Cancer Drug
1.2 Bile Duct Cancer Drug Segment by Type
1.2.1 Global Bile Duct Cancer Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Cabozantinib S-malate
1.2.3 Elpamotide
1.2.4 Exatecan Mesylate
1.2.5 LY-2801653
1.2.6 NUC-1031
1.2.7 Others
1.3 Bile Duct Cancer Drug Segment by Applications
1.3.1 Global Bile Duct Cancer Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Bile Duct Cancer Drug Overall Market
1.4.1 Global Bile Duct Cancer Drug Revenue (2014-2025)
1.4.2 Global Bile Duct Cancer Drug Production (2014-2025)
1.4.3 North America Bile Duct Cancer Drug Status and Prospect (2014-2025)
1.4.4 Europe Bile Duct Cancer Drug Status and Prospect (2014-2025)
1.4.5 China Bile Duct Cancer Drug Status and Prospect (2014-2025)
1.4.6 Japan Bile Duct Cancer Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Bile Duct Cancer Drug Status and Prospect (2014-2025)
1.4.8 India Bile Duct Cancer Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Bile Duct Cancer Drug
2.3 Manufacturing Process Analysis of Bile Duct Cancer Drug
2.4 Industry Chain Structure of Bile Duct Cancer Drug

3 Development and Manufacturing Plants Analysis of Bile Duct Cancer Drug
3.1 Capacity and Commercial Production Date
3.2 Global Bile Duct Cancer Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Bile Duct Cancer Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Bile Duct Cancer Drug Production and Capacity Analysis
4.2 Bile Duct Cancer Drug Revenue Analysis
4.3 Bile Duct Cancer Drug Price Analysis
4.4 Market Concentration Degree

5 Bile Duct Cancer Drug Regional Market Analysis
5.1 Bile Duct Cancer Drug Production by Regions
5.1.1 Global Bile Duct Cancer Drug Production by Regions
5.1.2 Global Bile Duct Cancer Drug Revenue by Regions
5.2 Bile Duct Cancer Drug Consumption by Regions
5.3 North America Bile Duct Cancer Drug Market Analysis
5.3.1 North America Bile Duct Cancer Drug Production
5.3.2 North America Bile Duct Cancer Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Bile Duct Cancer Drug Import and Export
5.4 Europe Bile Duct Cancer Drug Market Analysis
5.4.1 Europe Bile Duct Cancer Drug Production
5.4.2 Europe Bile Duct Cancer Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Bile Duct Cancer Drug Import and Export
5.5 China Bile Duct Cancer Drug Market Analysis
5.5.1 China Bile Duct Cancer Drug Production
5.5.2 China Bile Duct Cancer Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Bile Duct Cancer Drug Import and Export
5.6 Japan Bile Duct Cancer Drug Market Analysis
5.6.1 Japan Bile Duct Cancer Drug Production
5.6.2 Japan Bile Duct Cancer Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Bile Duct Cancer Drug Import and Export
5.7 Southeast Asia Bile Duct Cancer Drug Market Analysis
5.7.1 Southeast Asia Bile Duct Cancer Drug Production
5.7.2 Southeast Asia Bile Duct Cancer Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Bile Duct Cancer Drug Import and Export
5.8 India Bile Duct Cancer Drug Market Analysis
5.8.1 India Bile Duct Cancer Drug Production
5.8.2 India Bile Duct Cancer Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Bile Duct Cancer Drug Import and Export

6 Bile Duct Cancer Drug Segment Market Analysis (by Type)
6.1 Global Bile Duct Cancer Drug Production by Type
6.2 Global Bile Duct Cancer Drug Revenue by Type
6.3 Bile Duct Cancer Drug Price by Type

7 Bile Duct Cancer Drug Segment Market Analysis (by Application)
7.1 Global Bile Duct Cancer Drug Consumption by Application
7.2 Global Bile Duct Cancer Drug Consumption Market Share by Application (2014-2019)

8 Bile Duct Cancer Drug Major Manufacturers Analysis
8.1 Ariad Pharmaceuticals, Inc.
8.1.1 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production Sites and Area Served
8.1.2 Ariad Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.1.3 Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 ArQule, Inc.
8.2.1 ArQule, Inc. Bile Duct Cancer Drug Production Sites and Area Served
8.2.2 ArQule, Inc. Product Introduction, Application and Specification
8.2.3 ArQule, Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Array BioPharma Inc.
8.3.1 Array BioPharma Inc. Bile Duct Cancer Drug Production Sites and Area Served
8.3.2 Array BioPharma Inc. Product Introduction, Application and Specification
8.3.3 Array BioPharma Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Arrien Pharmaceuticals, LLC
8.4.1 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production Sites and Area Served
8.4.2 Arrien Pharmaceuticals, LLC Product Introduction, Application and Specification
8.4.3 Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Aslan Pharmaceuticals Pte. Ltd.
8.5.1 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production Sites and Area Served
8.5.2 Aslan Pharmaceuticals Pte. Ltd. Product Introduction, Application and Specification
8.5.3 Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Bavarian Nordic A/S
8.6.1 Bavarian Nordic A/S Bile Duct Cancer Drug Production Sites and Area Served
8.6.2 Bavarian Nordic A/S Product Introduction, Application and Specification
8.6.3 Bavarian Nordic A/S Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Bayer AG
8.7.1 Bayer AG Bile Duct Cancer Drug Production Sites and Area Served
8.7.2 Bayer AG Product Introduction, Application and Specification
8.7.3 Bayer AG Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Blueprint Medicines Corporation
8.8.1 Blueprint Medicines Corporation Bile Duct Cancer Drug Production Sites and Area Served
8.8.2 Blueprint Medicines Corporation Product Introduction, Application and Specification
8.8.3 Blueprint Medicines Corporation Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Boehringer Ingelheim GmbH
8.9.1 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production Sites and Area Served
8.9.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
8.9.3 Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Boston Biomedical, Inc.
8.10.1 Boston Biomedical, Inc. Bile Duct Cancer Drug Production Sites and Area Served
8.10.2 Boston Biomedical, Inc. Product Introduction, Application and Specification
8.10.3 Boston Biomedical, Inc. Bile Duct Cancer Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Bristol-Myers Squibb Company
8.12 Celgene Corporation
8.13 CellAct Pharma GmbH
8.14 Cellceutix Corporation
8.15 Cellular Biomedicine Group, Inc.
8.16 Concordia Healthcare Corp.

9 Development Trend of Analysis of Bile Duct Cancer Drug Market
9.1 Global Bile Duct Cancer Drug Market Trend Analysis
9.1.1 Global Bile Duct Cancer Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Bile Duct Cancer Drug Regional Market Trend
9.2.1 North America Bile Duct Cancer Drug Forecast 2019-2025
9.2.2 Europe Bile Duct Cancer Drug Forecast 2019-2025
9.2.3 China Bile Duct Cancer Drug Forecast 2019-2025
9.2.4 Japan Bile Duct Cancer Drug Forecast 2019-2025
9.2.5 Southeast Asia Bile Duct Cancer Drug Forecast 2019-2025
9.2.6 India Bile Duct Cancer Drug Forecast 2019-2025
9.3 Bile Duct Cancer Drug Market Trend (Product Type)
9.4 Bile Duct Cancer Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Bile Duct Cancer Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Bile Duct Cancer Drug
Table Global Bile Duct Cancer Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Bile Duct Cancer Drug Production Market Share by Types in 2018
Figure Cabozantinib S-malate Product Picture
Figure Elpamotide Product Picture
Figure Exatecan Mesylate Product Picture
Figure LY-2801653 Product Picture
Figure NUC-1031 Product Picture
Figure Others Product Picture
Table Global Bile Duct Cancer Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Bile Duct Cancer Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Bile Duct Cancer Drug Revenue (Million USD) (2014-2025)
Figure Global Bile Duct Cancer Drug Production (K Pcs) (2014-2025)
Figure North America Bile Duct Cancer Drug Market Size (Million USD) (2014-2025)
Figure Europe Bile Duct Cancer Drug Market Size (Million USD) (2014-2025)
Figure China Bile Duct Cancer Drug Market Size (Million USD) (2014-2025)
Figure Japan Bile Duct Cancer Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Bile Duct Cancer Drug Market Size (Million USD) (2014-2025)
Figure India Bile Duct Cancer Drug Market Size (Million USD) (2014-2025)
Table Bile Duct Cancer Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Bile Duct Cancer Drug in 2018
Figure Manufacturing Process Analysis of Bile Duct Cancer Drug
Figure Industry Chain Structure of Bile Duct Cancer Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Bile Duct Cancer Drug Manufacturing Plants Distribution
Table Bile Duct Cancer Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Bile Duct Cancer Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Bile Duct Cancer Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Bile Duct Cancer Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Bile Duct Cancer Drug Production Share by Manufacturers in 2018
Table Bile Duct Cancer Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Bile Duct Cancer Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Bile Duct Cancer Drug Revenue Share by Manufacturers in 2018
Table Bile Duct Cancer Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Bile Duct Cancer Drug Production by Regions 2014-2019 (K Pcs)
Table Global Bile Duct Cancer Drug Production Market Share by Regions 2014-2019
Figure Global Bile Duct Cancer Drug Production Market Share by Regions in 2018
Table Global Bile Duct Cancer Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Bile Duct Cancer Drug Revenue Market Share by Regions 2014-2019
Figure Global Bile Duct Cancer Drug Revenue Market Share by Regions in 2018
Table Global Bile Duct Cancer Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Bile Duct Cancer Drug Consumption Market Share by Regions 2014-2019
Figure North America Bile Duct Cancer Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Bile Duct Cancer Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Bile Duct Cancer Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Bile Duct Cancer Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Bile Duct Cancer Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Bile Duct Cancer Drug Production, Consumption Import and Export (K Pcs)
Figure China Bile Duct Cancer Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Bile Duct Cancer Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Bile Duct Cancer Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Bile Duct Cancer Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Bile Duct Cancer Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Bile Duct Cancer Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Bile Duct Cancer Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Bile Duct Cancer Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Bile Duct Cancer Drug Production, Consumption Import and Export (K Pcs)
Figure India Bile Duct Cancer Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Bile Duct Cancer Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Bile Duct Cancer Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Bile Duct Cancer Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Bile Duct Cancer Drug Market Share by Application (2014-2019)
Table Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production Sites and Area Served
Table Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Ariad Pharmaceuticals, Inc. Bile Duct Cancer Drug Main Business and Markets Served
Table ArQule, Inc. Bile Duct Cancer Drug Production Sites and Area Served
Table ArQule, Inc. Bile Duct Cancer Drug Product Introduction, Application and Specification
Table ArQule, Inc. Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ArQule, Inc. Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table ArQule, Inc. Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure ArQule, Inc. Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table ArQule, Inc. Bile Duct Cancer Drug Main Business and Markets Served
Table Array BioPharma Inc. Bile Duct Cancer Drug Production Sites and Area Served
Table Array BioPharma Inc. Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Array BioPharma Inc. Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Array BioPharma Inc. Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Array BioPharma Inc. Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Array BioPharma Inc. Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Array BioPharma Inc. Bile Duct Cancer Drug Main Business and Markets Served
Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production Sites and Area Served
Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Arrien Pharmaceuticals, LLC Bile Duct Cancer Drug Main Business and Markets Served
Table Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production Sites and Area Served
Table Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Aslan Pharmaceuticals Pte. Ltd. Bile Duct Cancer Drug Main Business and Markets Served
Table Bavarian Nordic A/S Bile Duct Cancer Drug Production Sites and Area Served
Table Bavarian Nordic A/S Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Bavarian Nordic A/S Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bavarian Nordic A/S Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Bavarian Nordic A/S Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Bavarian Nordic A/S Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Bavarian Nordic A/S Bile Duct Cancer Drug Main Business and Markets Served
Table Bayer AG Bile Duct Cancer Drug Production Sites and Area Served
Table Bayer AG Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Bayer AG Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Bayer AG Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Bayer AG Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Bayer AG Bile Duct Cancer Drug Main Business and Markets Served
Table Blueprint Medicines Corporation Bile Duct Cancer Drug Production Sites and Area Served
Table Blueprint Medicines Corporation Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Blueprint Medicines Corporation Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Blueprint Medicines Corporation Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Blueprint Medicines Corporation Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Blueprint Medicines Corporation Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Blueprint Medicines Corporation Bile Duct Cancer Drug Main Business and Markets Served
Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production Sites and Area Served
Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Boehringer Ingelheim GmbH Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Boehringer Ingelheim GmbH Bile Duct Cancer Drug Main Business and Markets Served
Table Boston Biomedical, Inc. Bile Duct Cancer Drug Production Sites and Area Served
Table Boston Biomedical, Inc. Bile Duct Cancer Drug Product Introduction, Application and Specification
Table Boston Biomedical, Inc. Bile Duct Cancer Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boston Biomedical, Inc. Bile Duct Cancer Drug Production Growth Rate (2014-2019)
Table Boston Biomedical, Inc. Bile Duct Cancer Drug Production Market Share (2014-2019)
Figure Boston Biomedical, Inc. Bile Duct Cancer Drug Revenue Market Share (2014-2019)
Table Boston Biomedical, Inc. Bile Duct Cancer Drug Main Business and Markets Served
Table Bristol-Myers Squibb Company Bile Duct Cancer Drug Production Sites and Area Served
Table Celgene Corporation Bile Duct Cancer Drug Production Sites and Area Served
Table CellAct Pharma GmbH Bile Duct Cancer Drug Production Sites and Area Served
Table Cellceutix Corporation Bile Duct Cancer Drug Production Sites and Area Served
Table Cellular Biomedicine Group, Inc. Bile Duct Cancer Drug Production Sites and Area Served
Table Concordia Healthcare Corp. Bile Duct Cancer Drug Production Sites and Area Served
Figure Global Bile Duct Cancer Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Bile Duct Cancer Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Bile Duct Cancer Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Bile Duct Cancer Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Bile Duct Cancer Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Bile Duct Cancer Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Bile Duct Cancer Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Bile Duct Cancer Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Bile Duct Cancer Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Bile Duct Cancer Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Bile Duct Cancer Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Bile Duct Cancer Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Bile Duct Cancer Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Bile Duct Cancer Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Bile Duct Cancer Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Bile Duct Cancer Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Bile Duct Cancer Drug by Application (2019-2025)
Table Bile Duct Cancer Drug Distributors List
Table Bile Duct Cancer Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Ariad Pharmaceuticals, Inc.、ArQule, Inc.、Array BioPharma Inc.、Arrien Pharmaceuticals, LLC、Aslan Pharmaceuticals Pte. Ltd.、Bavarian Nordic A/S、Bayer AG、Blueprint Medicines Corporation、Boehringer Ingelheim GmbH、Boston Biomedical, Inc.、Bristol-Myers Squibb Company、Celgene Corporation、CellAct Pharma GmbH、Cellceutix Corporation、Cellular Biomedicine Group, Inc.、Concordia Healthcare Corp.、

★調査レポート[世界の胆管がん治療薬市場 2019年] (コード：DATA909X04528)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の胆管がん治療薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のGタンパク質結合胆汁酸受容体1市場 2019年
    DATA909X08273 / QYResearch / 2019年11月15日 / ※本調査レポートは、Gタンパク質結合胆汁酸受容体1の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、INT-777、RDX-98940、S-0071261、その他に、用途別には、下痢、脂質異常症、腎線維症、その他にセグメント区分し、Gタンパク質結合胆汁酸受容体1の世界市場を分析しました。 ・エグゼクティブ・サマリー ・Gタンパク質結合胆汁酸受容体1の世界市場概要 ・Gタンパク質結合胆汁酸受容体1の製造コスト構成分析 ・Gタンパク質結合胆汁酸受容体1の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・Gタンパク質結合胆汁酸受容体1の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・Gタンパク質結合胆汁酸受容体1のセグメント分析（種類別） （INT-777、RDX-98940、S-0071261、その他）...The global G Protein Coupled Bile Acid Receptor 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on G Protein Coupled Bile Acid Receptor 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall G Protein Coupled Bile Acid Receptor 1 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of G Protein Coupled Bile Acid Receptor 1 in...
  • 世界の小分子がん治療薬市場 2019年
    DATA909X15260 / QYResearch / 2019年11月20日 / ※本調査レポートは、小分子がん治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、サイトカイン、ヒト化モノクローナル抗体、その他に、用途別には、リンパ腫、骨髄腫、前立腺がん、その他にセグメント区分し、小分子がん治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・小分子がん治療薬の世界市場概要 ・小分子がん治療薬の製造コスト構成分析 ・小分子がん治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・小分子がん治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・小分子がん治療薬のセグメント分析（種類別） （サイトカイン、ヒト化モノクローナル抗体、その他）...The global Small Molecule Cancer Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Small Molecule Cancer Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Small Molecule Cancer Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Small Molecule Cancer Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の回腸ナトリウム/胆汁酸共輸送体市場 2019年
    DATA909X09547 / QYResearch / 2019年11月20日 / ※本調査レポートは、回腸ナトリウム/胆汁酸共輸送体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Elobixibat、GSK-2330672、A-4250、CJ-14199、その他に、用途別には、アラジール症候群、プルリトゥス、便秘、B型肝炎、その他にセグメント区分し、回腸ナトリウム/胆汁酸共輸送体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・回腸ナトリウム/胆汁酸共輸送体の世界市場概要 ・回腸ナトリウム/胆汁酸共輸送体の製造コスト構成分析 ・回腸ナトリウム/胆汁酸共輸送体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・回腸ナトリウム/胆汁酸共輸送体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・回腸ナトリウム/胆汁酸共輸送体のセグメント分析（種類別） （Elobixibat、GSK-2330672、A-4250、CJ-14199、その他）...The global Ileal Sodium/Bile Acid Cotransporter market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ileal Sodium/Bile Acid Cotransporter volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ileal Sodium/Bile Acid Cotransporter market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Ileal Sodium/Bile Acid Cotransporter in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の二重バレル抗体薬市場 2019年
    DATA909X06729 / QYResearch / 2019年11月15日 / ※本調査レポートは、二重バレル抗体薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、レモバブ、BLINCYTO、その他に、用途別には、肺がん、脳がん、肝臓がん、その他にセグメント区分し、二重バレル抗体薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・二重バレル抗体薬の世界市場概要 ・二重バレル抗体薬の製造コスト構成分析 ・二重バレル抗体薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・二重バレル抗体薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・二重バレル抗体薬のセグメント分析（種類別） （レモバブ、BLINCYTO、その他）...The global Double Barreled Antibodies Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Double Barreled Antibodies Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Double Barreled Antibodies Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Double Barreled Antibodies Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 乳がん診断および薬物技術の世界市場：規模・現状・予測2019-2025
    DATA909X18241 / QYResearch / 2019年11月25日 / ※当調査レポートでは、乳がん診断および薬物技術の世界市場について調査・分析し、乳がん診断および薬物技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（マンモグラフィ、生検、その他）、用途別（乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の乳がん診断および薬物技術市場動向 ・主要企業別マーケットシェア ・乳がん診断および薬物技術の種類別市場規模2014-2019 （マンモグラフィ、生検、その他） ・乳がん診断および薬物技術の用途別市場規模2014-2019 （乳管がん、浸潤性乳管がん、小葉がん、トリプルネガティブ乳がん） ・乳がん診断および薬物技術の北米市場：主要企業・種類別/用途別市場規模 ・乳がん診断および薬物技術のヨーロッパ市場：主要企業・種類別/用途別市場規模...Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.In 2018, the global Breast Cancer Diagnostic and Drug Technologies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Breast Cancer Diagnostic and Drug Technologies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Breast Cancer Diagnostic and Drug Technologies development in...
  • 世界のポリマー薬物コンジュゲート市場 2019年
    DATA909X13335 / QYResearch / 2019年11月20日 / ※本調査レポートは、ポリマー薬物コンジュゲートの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ポリマードックスコンジュゲート、ポリマーパクリタキセルコンジュゲート、ポリマーカンプトテシンコンジュゲート、ポリマー-プラチネートコンジュゲートに、用途別には、がん治療、白血病、肝炎、その他にセグメント区分し、ポリマー薬物コンジュゲートの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ポリマー薬物コンジュゲートの世界市場概要 ・ポリマー薬物コンジュゲートの製造コスト構成分析 ・ポリマー薬物コンジュゲートの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ポリマー薬物コンジュゲートの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ポリマー薬物コンジュゲートのセグメント分析（種類別） （ポリマードックスコンジュゲート、ポリマーパクリタキセルコンジュゲート、ポリマーカンプトテシンコンジュゲート、ポリマー-プラチネートコンジュゲート）...The global Polymer Drug Conjugates market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polymer Drug Conjugates volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polymer Drug Conjugates market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polymer Drug Conjugates in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆